Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.03 ($61,916)
  2. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $46.03 ($63,291)
  3. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $49.50 ($391,077)
  4. 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
  5. 4 Exercise or conversion EVP, Research & CSO acquired 3,500 shares (option exercise)
  6. 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $43.57 ($242,244)
  7. 4 Exercise or conversion EVP, Research & CSO acquired 14,000 shares (option exercise)
  8. 4 Other disposition Director disposed of 1,000,000 shares (other)
  9. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  10. 4 Open-market sale Chief Business Officer sold 6,944 shares at $51.40 ($356,956)
  11. 4 Other disposition Director disposed of 1,000,000 shares (other)
  12. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  13. 4 Grant or award Chief Technology Officer acquired 30,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $53.60 ($423,408)
  16. 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
  17. 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $44.80 ($249,086)
  18. 4 Open-market sale Chief Business Officer sold 6,944 shares at $63.44 ($440,531)
  19. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $63.74 ($503,577)
  20. 4 Grant or award CFO acquired 25,000 shares (grant or award)

Page 18 of 25 · 491 filings